Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-198109
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Cost of product sales, exclusive of depreciation expense shown below | 25,958 | 26,489 |
| General and administrative expense, exclusive of depreciation expense shown below | 14,718 | 13,647 |
| Depreciation | 3,556 | 3,593 |
| Amortization | 208 | 124 |
| Other (income) expense, net | (645) | 2,335 |
| OPERATING INCOME | 1,887 | 4,417 |
| Interest expense | 2,891 | 2,602 |
| Income (loss) before income taxes | (1,004) | 1,815 |
Item 1. Financial Statements
FAQ
- What is Core Laboratories's D&A?
- Core Laboratories (CLB) reported D&A of $208K in Q1 2026.
- How has Core Laboratories's D&A changed year-over-year?
- Core Laboratories's D&A increased by 67.7% year-over-year, from $124K to $208K.
- What is the long-term trend for Core Laboratories's D&A?
- Over 4 years (2021 to 2025), Core Laboratories's D&A has grown at a -17.2% compound annual growth rate (CAGR), from $762K to $359K.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Core Laboratories's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude